These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22311150)

  • 1. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.
    Erpolat OP; Gocun PU; Akmansu M; Karakus E; Akyol G
    Strahlenther Onkol; 2012 Mar; 188(3):248-54. PubMed ID: 22311150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.
    Qi G; Kudo Y; Ando T; Tsunematsu T; Shimizu N; Siriwardena SB; Yoshida M; Keikhaee MR; Ogawa I; Takata T
    Oral Oncol; 2010 Apr; 46(4):263-70. PubMed ID: 20138567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.
    Vischioni B; Oudejans JJ; Vos W; Rodriguez JA; Giaccone G
    Mol Cancer Ther; 2006 Nov; 5(11):2905-13. PubMed ID: 17121938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
    Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
    Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck.
    Hoellein A; Pickhard A; von Keitz F; Schoeffmann S; Piontek G; Rudelius M; Baumgart A; Wagenpfeil S; Peschel C; Dechow T; Bier H; Keller U
    Oncotarget; 2011 Aug; 2(8):599-609. PubMed ID: 21865609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas.
    Kim GY; Lim SJ; Kim YW
    Mod Pathol; 2011 Oct; 24(10):1336-47. PubMed ID: 21572400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects and expression of Survivin and Aurora-b in laryngeal carcinoma].
    Hu CH; Wang WH; Wang Q; He XS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 May; 31(10):737-743. PubMed ID: 29771033
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients.
    Knauer SK; Unruhe B; Karczewski S; Hecht R; Fetz V; Bier C; Friedl S; Wollenberg B; Pries R; Habtemichael N; Heinrich UR; Stauber RH
    Hum Mutat; 2013 Feb; 34(2):395-404. PubMed ID: 23161837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of survivin in pancreatic endocrine tumors.
    Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
    World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
    Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
    Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma.
    Grabowski P; Kühnel T; Mühr-Wilkenshoff F; Heine B; Stein H; Höpfner M; Germer CT; Scherübl H
    Br J Cancer; 2003 Jan; 88(1):115-9. PubMed ID: 12556969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival.
    Shen YC; Hu FC; Jeng YM; Chang YT; Lin ZZ; Chang MC; Hsu C; Cheng AL
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):417-23. PubMed ID: 19190145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.
    Sun PL; Jin Y; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Virchows Arch; 2013 Sep; 463(3):427-36. PubMed ID: 23907568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
    Pannone G; Hindi SA; Santoro A; Sanguedolce F; Rubini C; Cincione RI; De Maria S; Tortorella S; Rocchetti R; Cagiano S; Pedicillo C; Serpico R; Lo Muzio L; Bufo P
    Int J Immunopathol Pharmacol; 2011; 24(1):79-88. PubMed ID: 21496390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
    Marioni G; Ottaviano G; Marchese-Ragona R; Fasanaro E; Tealdo G; Zanotti C; Randon B; Giacomelli L; Stellini E; Blandamura S
    J Clin Pathol; 2017 Dec; 70(12):1033-1037. PubMed ID: 28446541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Study of Mitosis-regulatory Proteins in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Briest F; Wang Y; Arsenic R; Elezkurtaj S; Berg E; Greshake S; Lock AC; Hörsch D; Arnold CN; Hummel M; Siegmund B; Grabowski P
    Anticancer Res; 2018 Jul; 38(7):3863-3870. PubMed ID: 29970506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated up-regulation of human telomerase reverse transcriptase expression.
    Furuya M; Tsuji N; Kobayashi D; Watanabe N
    Int J Oncol; 2009 Apr; 34(4):1061-8. PubMed ID: 19287963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B.
    Tarnawski A; Pai R; Chiou SK; Chai J; Chu EC
    Biochem Biophys Res Commun; 2005 Aug; 334(1):207-12. PubMed ID: 15993841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.